*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
You are seeing these quotes based on previous browsing related to sectors such as
Reckitt Benckiser Group (RBL)
4,803.00p
16:30 20/12/24
-0.17%-8.00p
Today's Low & High
4,760.00 / 4,819.50
Open / Previous Close
4,819.50 / 4,803.00
52-week range
0.00%4,803.00p
Volume
207,360
Market Cap(million)
£33,963.58m
Advertising
Reckitt Benckiser Group - Overview
Reckitt and Benckiser both began life in the 19th century eventually merging over 100 years later in 1999 to become the worlds largest household cleaning products group. Over half the groups revenues are generated from its Fabric Care and Surface Care divisions, with the majority of its business centred in Western Europe. In 2005 Reckitt added the Nurofen, Strepsil and Clearasil brands to its portfolio with the £1.9bn acquisition of Boots Healthcare International.